<DOC>
<DOCNO>
EP-0008150
</DOCNO>
<TEXT>
<DATE>
19800220
</DATE>
<IPC-CLASSIFICATIONS>
C07D-233/00 A61P-9/00 A61P-9/12 C07D-233/88 <main>C07D-233/88</main> A61K-31/415 
</IPC-CLASSIFICATIONS>
<TITLE>
2,6-dichlorophenyl-substituted amino-imidazole derivatives,  processes of preparing such derivatives and pharmaceutical preparations comprising said derivatives.
</TITLE>
<APPLICANT>
farmos oy fi<sep>farmos-yhtyma oy<sep>farmos-yhtyma oyp.o. box 425sf-20101 turku 10fi<sep>farmos-yhtyma oy <sep>
</APPLICANT>
<INVENTOR>
karjalainen arto johannes<sep>kurkela kauko oiva antero<sep>karjalainen, arto johannes<sep>kurkela, kauko oiva antero<sep>karjalainen, arto johannesmyllyojantie 13 h 3790650 oulu 65fi<sep>kurkela, kauko oiva anterotakavainiontie 9 c 2690560 oulu 56fi<sep>karjalainen, arto johannes <sep>kurkela, kauko oiva antero  <sep>karjalainen, arto johannesmyllyojantie 13 h 3790650 oulu 65fi<sep>kurkela, kauko oiva anterotakavainiontie 9 c 2690560 oulu 56fi<sep>
</INVENTOR>
<ABSTRACT>
the 2,6-dichlorphenyl-substituted amino-imidazole de­ rivatives 1-(2′,6′-dichlorphenyl)-2-amino-4-methyl-imidaz­ ole, 2-(2′,6′-dichloroanilino)-4-methyl-imidazole, their non-­ toxic, pharmaceutically acceptable, acid addition salts and  mixtures thereof, exhibit excellent anti-hypertensive and  anti-ulcer activities which makes the derivatives particularly  suitable for treatment of high blood pressure and gastric  ulcers in mammals.  the derivatives may be prepared in either of two pro­ cesses.  the first process involves the sequential reaction  of a known starting material with ammonia and a halo­ genated acetone which may be followed by separation of  the formed isomers.  the second process involves the de­ carboxylation of the novel intermediates 4-[1-(2′,6′-di­ chlorphenyl)-2-amino)]-imidazoleacetic acid or 4-[2-(2′,6′-­ dichloranilino)]-imidazoleacetic acid or mixtures thereof.  the derivatives are employed in an effective amount  and are typically combined with a pharmaceutical carrier.   administration of the derivatives may be accomplished  either orally or parenterally.  
</ABSTRACT>
</TEXT>
</DOC>
